Impaired GPX4 activity elicits ferroptosis in alveolar type II cells promoting PHMG-induced pulmonary fibrosis

Wanjun Zhang1, Zhaolong Sun1, Wenting Cheng2

  • 1Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250001, China; Departmental of Occupational and Environmental Health, School of Public Health, Qingdao University, Qingdao 266071, China.

Insights

Polyhexamethylene guanidine (PHMG) inhalation causes pulmonary fibrosis by inducing ferroptosis, a cell death pathway. Inhibiting ferroptosis may offer a new treatment for this lung injury.

Area of Science:

  • Toxicology
  • Cell Biology
  • Pulmonary Medicine

Background:

  • Polyhexamethylene guanidine (PHMG) is a disinfectant linked to severe pulmonary fibrosis.
  • Ferroptosis, an iron-dependent cell death, is implicated in chemical-induced lung injury.

Purpose of the Study:

  • To investigate the role of ferroptosis in PHMG-induced pulmonary fibrosis.
  • To explore PHMG's toxicity mechanism in lung cells and animal models.

Main Methods:

  • Utilized C57BL/6J mice and MLE-12 alveolar cells for in vivo and in vitro studies.
  • Assessed iron deposition, ferroptosis gene expression, antioxidant system, mitochondrial function, and lipid peroxidation.
  • Evaluated the effects of ferroptosis inhibitors Ferrostatin-1 (Fer-1) and Liproxstatin-1 (Lip-1).

Main Results:

  • PHMG exposure led to iron deposition and altered ferroptosis gene expression in mice.
  • PHMG induced oxidative stress, mitochondrial damage, increased lipid peroxidation, and decreased GPX4 activity in MLE-12 cells.
  • Ferrostatin-1 and Liproxstatin-1 treatments reversed these cellular changes.

Conclusions:

  • Ferroptosis pathway plays a significant role in PHMG-induced pulmonary fibrosis.
  • Targeting ferroptosis presents a potential therapeutic strategy for PHMG-related lung damage.